ZTEK - Gunggunge utang jangka dawa Zentek Ltd

The market trend for Zentek Ltd. (ZTEK) demonstrates long-term debt amounting to 0.00. The brand's competitive advantage is based on exclusive rights to graphene coatings and biotechnology support under strict FDA control. Zentek Ltd. (ZTEK) is implementing automated workshops for nanomaterial production and the digitalization of sensor analysis. The business relies on the protected healthcare sector while remaining dependent on investments in innovation development.

An analysis of the financial stability of Zentek Ltd. requires an evaluation of its capital structure to understand the company's ability to fund expansion. The amount of liabilities with a maturity of more than one year, reflected through the monitoring of the enterprise's long-term debt, demonstrates the volume of borrowed funds necessary to scale unique patents in the graphene and medical fields amid the current lack of mass product commercialization.